Related Experiment Video
Updated: Jun 5, 2026
13:09
Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Supporting Medication Adherence and Patient-Centered Care for Attention-Deficit Hyperactivity Disorder in Taiwan: A
Yu-Jui Chiu1, Yen-Ming Huang1,2,3
1School of Pharmacy, College of Medicine, National Taiwan University, Taipei City, 100025, Taiwan.
Patient Preference and Adherence
|March 3, 2026
Summary
Taiwan
Area of Science:
- Pediatric Psychiatry
- Pharmacology
- Health Services Research
Background:
- Attention-deficit/hyperactivity disorder (ADHD) care in Taiwan faces significant treatment retention challenges.
- A gap exists between ADHD diagnosis rates and sustained long-term treatment adherence.
- Existing hospital-centered models may inadequately support continuous ADHD management.
Purpose of the Study:
- To synthesize evidence on factors contributing to medication non-adherence in pediatric ADHD patients in Taiwan.
- To propose a pharmacist-driven precision approach to enhance ADHD treatment adherence.
Main Methods:
- Application of the SPIDER framework to review existing literature.
- Categorization of adherence barriers into five domains: medication, child, family, school, and healthcare system.
- Development of a novel pharmacist-led intervention strategy.
Main Results:
- Multidimensional barriers to ADHD medication adherence identified, including dosing complexity, developmental autonomy, socioeconomic factors, school stigma, and system-level issues.
- Hospital-centric care models are insufficient for sustained treatment engagement.
- A pharmacist-driven approach offers a viable solution to improve adherence.
Conclusions:
- Addressing ADHD medication non-adherence requires a multifaceted strategy beyond hospital settings.
- A pharmacist-driven precision approach, involving regimen optimization and digital tools, can improve treatment persistence.
- Community pharmacists can act as key facilitators for sustained ADHD care across different life stages.
Keywords:
attention-deficit hyperactivity disorderinterventionmedication adherencepharmacistshared decision-makingMore Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Modeling in Therapy
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.